MRNA - A letter of Public Interest....
These 2 Biotechs
Just Got a $1.9 Billion Vaccine Order
By Ian Wyatt | July 22, 2020
Earn 724% Profits from America’s #1 Biotech: One little-known American biotech stock soared 159%. Yet smart investors cashed in 724% profits in less than 60 days using this trade. Go here to get my next trade alert.
The U.S. government is pulling out the stops.
Today the Department of Health & Human Services agreed to buy millions of new Covid-19 vaccines.
The initial order includes 100 million vaccines at a cost of $1.95 billion. The deal also allows the government to acquire an additional 500 million vaccines.
It’s part of the governments initiative to vaccinate every American.
The vaccine is known as BNT162.
Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) are partners on the vaccine.
BioNTech is using a technology called mRNA to develop the vaccine. Pfizer will be responsible for manufacturing the vaccine.
The companies are working on four separate experimental vaccines.
They’re prepared to deliver the initial 100 million doses by December. Another 1.3 billion doses could be manufactured by the end of 2021.
Regular investors are already profiting from these biotech stocks. Yet a small group of traders are earning 3X… 5X… and even 10X bigger profits as these stocks soar.
Click here to discover how to make 724% profits from my #1 biotech.
The Big News…
LIVE TRADING: Overnight Trader Reveals How to Turn $5k into $2.8 Million
Imagine starting with a small $5,000 investment – and turning it into over $2.8 million. Now that may sound impossible --- until you see these quick 24-hour overnight trades. Discover exactly how this possible. Click here to start today.
U.S. Tops 1,000 Deaths in 24-Hours
The death toll in America is rising once again. This follows weeks of growing numbers of Covid-19 cases in the country. Deaths typically lag confirmed cases by 10 -14 days. Tuesday’s deaths were at least 1,120. This was the highest level since May 29.
U.S. Military Reports 21,000 Cases
The military is reporting over 21,000 infections in the armed services. The infection rate has tripled in just six weeks.
CDC Says Total Cases Are 2X – 13X Higher
The Centers for Disease Control says that current reports greatly underestimate Covid-19 cases. 40% of people do not have any symptoms – and therefore are not getting tested. Today the U.S. is testing 700,000 people per day. At a minimum, the number of cases is double the reported number.
Grab 918% Profits with Netflix, Paypal and Shopify
Discover top Wall Street strategy for multiplying your profits – WITHOUT buying a single share of stock. You could start earning triple digit profits in less than 90-days. Click here ASAP for the next trade alert.
The Coronavirus Numbers
Here are the numbers from Monday at 12:10pm ET.
•15,151,738 Infected worldwide
•621,122 deaths worldwide
•4,030,936 Infected in the U.S.
•144,987 Deaths in the U.S.
What's Next?
Stocks continued to move slightly higher on Wednesday.
News of an order for 100 million vaccines from Pfizer is certainly a positive for the market. It suggests that the U.S. government believes the company is on the cusp of a successful vaccine.
That positive news outweighed increased tensions between the U.S. and China. The market appears to be discounting this and focusing on positive developments related to the vaccine.
All eyes also continue to be on corporate earnings.
Earnings for the S&P 500 are expected to drop 44% during the second quarter, according to FactSet Research.
Despite all the uncertainty…
Today is the very best time for these quick, 24-hour Overnight Trades.
Tomorrow’s LIVE trade could hand you quick gains of $1,000 - $2,000 – even if you’re trading with a small account.
Just click here ASAP for the next trade.
Yours in Health & Wealth,
Ian Wyatt
CORONAVIRUS ALERTS NEWSLETTER
If you have any questions about your subscription, please contact Customer Care at 866-447-8625 or 802-448-8410. Monday - Friday between 9:00 a.m. and 5:00 p.m. ET
Wyatt Investment Research | 65 Railroad Street | Richmond, VT 05477 USA
Toll Free: 866-447-8625 or International: 802-448-8410
Web Site: www.wyattresearch.com
Email Customer Service: customerservice@wyattresearch.com
Disclaimer & Important Information
WyattResearch.com is owned and published by Wyatt Investment Research. Wyatt Investment Research is neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security.
If you believe this communication to be a mistake or unsolicited, please forward this email to abuse@wyattresearchnewsletters.com and be sure to include details regarding your situation. We will be sure to promptly investigate your situation and get back to you within 4-7 business days.
Copyright (c) 2020 Wyatt Investment Research.
Wyatt Investment Research
65 Railroad Street
Richmond, VT 05477
PO Box 790
Terms | Privacy | Email Policy | Compensation | Disclosure
Unsubscribe | Delivery Preferences
Facebook
